 
| Course: |
Infectious Diseases 1605
|
| Target Audience: |
| This activity is intended for the infectious disease specialist. |
| Sponsor: |
| This activity is sponsored by AHC Media. |
| Accreditation: |
| AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
| Credit Designation: |
| AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. |
| Faculty |
Editor
Stan Deresinski, MD, FACP, FIDSA
Clinical Professor of Medicine
Stanford University
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center
Board Member and Updates Author
Carol A. Kemper, MD, FACP
Section Editor Updates
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center
Board Member and Peer Reviewer
Timothy Jenkins, MD
Assistant Professor of Medicine
br /
University of Colorado
Denver Health Medical Center
Associate Editor
Hal B. Jenson, MD, FAAP
Dean, School of Medicine
Western Michigan University School of Medicine
Kalamazoo, MI
Authors
William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Assistant Professor of Medicine
University of California
San Francisco
James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA.
Maria D. Mileno MD
Director, Travel Medicine
The Miriam Hospital and Associate Professor of Medicine
Brown University
Providence, RI
Philip R. Fischer, MD, DTM&H
Professor of Pediatrics,
Department of Pediatric and Adolescent Medicine
Mayo Clinic
Rochester MN
|
| Subjects: |
- TB in the U.S. Things Continue to Improve, But There is a Long Road Ahead
- Nasopharyngeal Bacterial Changes with Antimicrobials and Pneumococcal Vaccine
- Age of Primary Epstein-Barr Virus Infection Affects Immune Control
- Ivermectin Lotion 0.5% (Sklice)
- Cystic Cerebellar Lesions Post Honeymoon: A Strange Case of Neurocysticercosis
- Dengue in Pediatric Travelers
- Updates
|
| Objectives: |
- discuss the diagnosis and treatment of infectious diseases
- explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
- discuss the latest information regarding risks, benefits and cost-effectiveness of new and traditional diagnostic tests
- discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies
|
| Financial Disclosure: |
Infectious Disease Alert's Editor, Stan Deresinski, MD, FACP, FIDSA, does research for the National Institutes of Health, and is an advisory board member and consultant for Merck.
Updates Author Carol A. Kemper, MD, FACP, does research for Abbott Laboratories, and Merck.
Peer Reviewer Timothy Jenkins, MD, Associate Editor Hal B. Jenson, MD, FAAP, Authors William T. Elliott, MD, FACP, James Chan, PharmD, PhD, Maria D. Mileno MD, and Philip R. Fischer, MD, DTM&H report no financial relationship relavent to this field of study.
Copyright 2012 AHC Media. All rights reserved.
|
- You are not currently logged in.
- To view content articles and complete the post-test for this course, please login or register now
|
|
